The woman had a low number of platelets and blood clots in small and large vessels, as well as bleeding.
A number of similar cases have been found in Norway and in the database of the European Medicines Agency (EMA) on side effects on medicines, the Danish Medicines Agency said.
“It was an unusual course of illness surrounding the death that caused the Danish Medicines Agency to respond,” he said in a statement late Sunday.
Norway said on Saturday that three people, all under the age of 50, who had received the AstraZeneca vaccine were being treated in hospital for bleeding, blood clots and a low platelet count, which were described by health authorities as “unusual symptoms”.
Denmark, Norway and Iceland said last week they would discontinue the introduction of the AstraZeneca vaccine.
European vaccination programs have been upset over the past two weeks by reports that recipients of the AstraZeneca vaccination have contracted blood clots.
cnxps.cmd.push (function () {cnxps ({playerId: ’36af7c51-0caf-4741-9824-2c941fc6c17b’}). deliver (‘4c4d856e0e6f4e3d808bbc1715e132f6’);});
if (window.location.pathname.indexOf (“656089”)! = -1) {console.log (“hedva connatix”); document.getElementsByClassName (“divConnatix”)[0].style.display = “none”;}
The European Medicines Agency said there was no indication that the events were caused by the vaccination, a view expressed by the World Health Organization on Friday.